Jade Biosciences JBIO Total debt

Total debt at other companies

Vertex PharmaceuticalsVRTX

$1.98B+29.5%

Climb Global Solutions, Inc.CLMB

$1.79M-36.3%

Travere Therapeutics, Inc.TVTX

$15.58M-82.6%

Vera TherapeuticsVERA

$75.03M+37.8%

Vor BiopharmaVOR

$2.94M-90.5%

AnaptysBio, Inc.ANAB

$13.61K-99.9%

FAQ

What is Jade Biosciences's total debt?

Jade Biosciences (JBIO) reported total debt of $808K in Q1 2026.

How has Jade Biosciences's total debt changed year-over-year?

Jade Biosciences's total debt increased by 159.0% year-over-year, from $312K to $808K.

What is the long-term trend for Jade Biosciences's total debt?

Over 4 years (2021 to 2025), Jade Biosciences's total debt has grown at a 10.3% compound annual growth rate (CAGR), from $574K to $851K.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.